Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of human lymphocyte function by C3a and C3a(70-77)

D G Payan, D E Trentham, E J Goetzl

    The Journal of Experimental Medicine
    |September 1, 1982
    PubMed
    Summary

    Human C3a, a complement system component, and its synthetic form C3a (70-77) inhibit leukocyte inhibitory factor (LIF) generation in T lymphocytes. This suggests C3a plays a role in regulating T cell activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Approaches to discovering drugs that regulate E3 ubiquitin ligases.

    Ernst Schering Foundation symposium proceedings·2009
    Same author

    Amiprilose hydrochloride for the treatment of rheumatoid arthritis.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    Treatment of rheumatic disease by tumor necrosis factor-alpha blockade: knowns and unknowns.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2006
    Same author

    Stable, stoichiometric delivery of diverse protein functions.

    Journal of biochemical and biophysical methods·2004
    Same author

    Utility of peptide-protein affinity complexes in proteomics: identification of interaction partners of a tumor suppressor peptide.

    The journal of peptide research : official journal of the American Peptide Society·2003
    Same author

    The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics.

    Current opinion in biotechnology·2002

    Area of Science:

    • Immunology
    • Complement System Biology
    • Cellular Immunology

    Background:

    • The complement system is crucial for innate and adaptive immunity.
    • Leukocyte inhibitory factor (LIF) modulates immune cell migration and function.
    • C3a is a potent anaphylatoxin generated during complement activation.

    Purpose of the Study:

    • To investigate the effect of human C3a and its synthetic octapeptide C3a (70-77) on leukocyte inhibitory factor (LIF) generation in human mononuclear leukocytes and T lymphocytes.
    • To determine if C3a influences T lymphocyte proliferation or migration.
    • To elucidate the mechanism of C3a interaction with leukocytes involved in LIF production.

    Main Methods:

    • Human mononuclear leukocytes and T lymphocytes were cultured with mitogens (PHA, Con A) or antigen (SK-SD).
    • The generation of LIF activity was measured in the presence of varying concentrations of C3a and C3a (70-77).
    • Lymphocyte proliferation ([3H]thymidine uptake) and migration assays were performed.
    • C3a (70-77)-Sepharose affinity chromatography was used to identify interacting cells.
    • Monoclonal antibodies were used to analyze lymphocyte populations.

    Main Results:

    • Both C3a and C3a (70-77) inhibited LIF generation in a concentration-dependent manner.
    • The synthetic C3a (70-77) was less potent than native C3a when stimulated by antigen (SK-SD).
    • C3a (70-77) inhibited T lymphocyte migration.
    • Neither C3a nor C3a (70-77) significantly affected [3H]thymidine uptake, indicating no general effect on proliferation.
    • C3a (70-77)-Sepharose selectively depleted helper/inducer T lymphocytes, suggesting direct interaction.

    Conclusions:

    • Human C3a and C3a (70-77) directly inhibit LIF generation and T lymphocyte migration.
    • C3a selectively targets and depletes helper/inducer T lymphocytes.
    • C3a is implicated as a key mediator in the complement system's regulation of human T lymphocyte functions.

    Related Experiment Videos